Patrick Schwab
@schwabpa
Senior Director Machine Learning & AI @GSK. Prev: ML @Roche, PhD @ETH. ML for Drug Discovery and Health.
Save the date! Machine Learning for Drug Discovery (MLDD) is happening soon on Monday 30 June, 2025. MLDD aims to bring together ML for drug discovery experts, innovators, and enthusiasts from the machine learning, biotechnology and drug discovery domains in London, UK to…
In the age of language models, where the most frequently voiced opinion is readily available at everyone's fingertips, a scientists greatest asset is to cultivate a small but well-informed set of beliefs that yet go against conventional wisdom.
reprogramming cells with transcription factors is our most expressive tool for engineering cell state traditionally, we found TFs by ~guesswork @icmlconf we're sharing @newlimit's SOTA AI models that can design reprogramming payloads by building on molecular foundation models
why don’t we have more medicines? inventing medicines has grown less efficient, limited by our knowledge of biological targets for the 1st time, AI & genomics have the potential to make this knowledge abundant – one of the largest potential impacts of the intelligence age.
The proposed analogy between interpreting machine learning and biology really does not hold up at all Understanding biology is hard precisely because it doesn’t have any of the properties that make understanding machine learning models (relatively) easy - full observability, no…
Excited to launch our AlphaGenome API goo.gle/3ZPUeFX along with the preprint goo.gle/45AkUyc describing and evaluating our latest DNA sequence model powering the API. Looking forward to seeing how scientists use it! @GoogleDeepMind